Clinical

Dataset Information

0

Regorafenib Combined With Irinotecan Drug-Eluting Beads for Colorectal Cancer Liver Metastases


ABSTRACT: This study is a multicentre, prospective, randomised trial, aims to evaluate the efficacy and safety of Irinotecan Drug-Eluting Beads combined with regorafenib as the third-line treatment for a patient with colorectal cancer liver metastases. The study is planned to enrolled 126 patients failing first- and second-line standard chemotherapy treatment.

DISEASE(S): Regorafenib,Neoplasm Metastasis,Colorectal Neoplasms,Liver Neoplasms,Colorectal Cancer Liver Metastases

PROVIDER: 13484 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2379485 | ecrin-mdr-crc
| 2105402 | ecrin-mdr-crc
| 2254991 | ecrin-mdr-crc
2010-03-01 | GSE19136 | GEO
2010-03-07 | E-GEOD-19136 | biostudies-arrayexpress
| 2164492 | ecrin-mdr-crc
| 2182836 | ecrin-mdr-crc
2011-04-22 | E-GEOD-28781 | biostudies-arrayexpress
2011-04-22 | GSE28781 | GEO
| S-EPMC6663477 | biostudies-literature